Ryman Healthcare Limited (ASX:RYM)
Australia · Delayed Price · Currency is AUD 2.350
-0.020 (-0.84%)
At close: Feb 5, 2026
Ryman Healthcare Market Cap
Ryman Healthcare has a market cap or net worth of 2.39 billion as of February 5, 2026. Its market cap has decreased by -13.35% in one year.
Market Cap
2.39B
Enterprise Value
3.84B
Revenue
707.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.35
Market Cap Chart
Since June 6, 2000, Ryman Healthcare's market cap has increased from 137.62M to 2.39B, an increase of 1,640.00%. That is a compound annual growth rate of 11.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 2.39B | -5.98% |
| Dec 31, 2025 | 2.55B | -12.90% |
| Dec 31, 2024 | 2.92B | -22.13% |
| Dec 29, 2023 | 3.76B | 49.41% |
| Dec 30, 2022 | 2.51B | -56.17% |
| Dec 31, 2021 | 5.73B | -18.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.38B |
| Pro Medicus | 18.61B |
| Cochlear | 17.41B |
| Sonic Healthcare | 11.26B |
| Ansell | 4.63B |
| Telix Pharmaceuticals | 3.55B |
| Mesoblast | 3.19B |
| Neuren Pharmaceuticals | 2.06B |